首页 | 本学科首页   官方微博 | 高级检索  
检索        

人参皂苷Rb1可能通过CDK5途径减轻Aβ25-35诱导的胎鼠海马神经元tau蛋白过度磷酸化
引用本文:谢玉华,陈晓春,张静,黄天文,宋锦秋,方雅秀,潘晓东,林智颖.人参皂苷Rb1可能通过CDK5途径减轻Aβ25-35诱导的胎鼠海马神经元tau蛋白过度磷酸化[J].药学学报,2007,42(8):828-832.
作者姓名:谢玉华  陈晓春  张静  黄天文  宋锦秋  方雅秀  潘晓东  林智颖
作者单位:福建医科大学,附属协和医院,福建省老年医学研究所,福建,福州,350001
基金项目:福建省科技攻关项目;福建医科大学校科研和教改项目
摘    要:观察人参皂苷Rb1对Aβ25-35诱导的海马神经元tau蛋白过度磷酸化的影响,并探讨其对周期依赖性蛋白激酶(cyclin-dependent kinase 5,CDK5)及激动亚基p25/p35的可能作用。通过蛋白免疫印迹法和免疫细胞化学染色法检测胎鼠海马神经元tau蛋白在Thr205、Ser396和Ser404位点的磷酸化水平,及CDK5的两个亚基cdk5和p25/p35的蛋白水平。20 μmol·L-1凝聚态Aβ25-35作用于海马神经元12 h,可使海马神经元tau蛋白在Thr205、Ser396和Ser404位点的磷酸化水平增高,p25的数量增多,但并不影响cdk5亚基的表达。人参皂苷Rb1可减轻凝聚态Aβ25-35诱导的海马神经元tau蛋白的过度磷酸化,抑制p35的降解并减少海马神经元p25的生成。人参皂苷Rb1可能通过CDK5途径减轻Aβ25-35诱导的胎鼠海马神经元tau蛋白过度磷酸化。

关 键 词:人参皂苷Rb1  β淀粉样蛋白25-35  tau蛋白  CDK5  p25/p35
文章编号:0513-4870(2007)08-0828-05
修稿时间:2006-12-07

Ginsenoside Rb1 attenuates β-amyloid peptide25-35-induced hyperphosphorylation of tau protein through CDK5 signal pathway
XIE Yu-hua,CHEN Xiao-chun,ZHANG Jing,HUANG Tian-wen,SONG Jin-qiu,FANG Ya-xiu,PAN Xiao-dong,LIN Zhi-ying.Ginsenoside Rb1 attenuates β-amyloid peptide25-35-induced hyperphosphorylation of tau protein through CDK5 signal pathway[J].Acta Pharmaceutica Sinica,2007,42(8):828-832.
Authors:XIE Yu-hua  CHEN Xiao-chun  ZHANG Jing  HUANG Tian-wen  SONG Jin-qiu  FANG Ya-xiu  PAN Xiao-dong  LIN Zhi-ying
Institution:Fujian Institute of Geriatrics, Affiliated Union Hospital of Fujian Medical University, Fuzhou 350001, China.
Abstract:This study is to explore the effect of ginsenoside Rb1 on the process of beta-amyloid peptide(25-35) (Abeta(25-35)) -induced hyperphosphorylation of tau protein, and on the level of cyclin-dependent kinase 5 activator, p25/p35. Western blotting and/or immunocytochemical staining were used to detect the levels of phosphorylation of tau protein at the sites of Thr205, Ser396, Ser404 in hippocampal neurons, cdk5 and p25/p35. After exposure to Abeta(25-35) (20 micromol x L(-1)) for 12 h, the levels of tau protein phosphorylation at the sites of Thr205, Ser396, Ser404 were enhanced, the level of p25 was increased, but the level of protein cdk5 was not changed markedly. Pretreatment with ginsenoside Rb1 reduced Abeta(25-35) -induced hyperphosphorylation of tau protein and decreased the lever of p25, but had no effect on cdk5. Ginsenoside Rb1 can attenuate Abeta(25-35) -induced hyperphosphorylation of tau protein through CDK5 signal pathway.
Keywords:CDK5  p25/p35
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《药学学报》浏览原始摘要信息
点击此处可从《药学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号